|
Volumn 29, Issue 1, 1994, Pages 117-125
|
Epidermal growth factor receptor expression in breast cancer: Association with response to endocrine therapy
|
Author keywords
breast cancer; c erbB 2; endocrine therapy; epidermal growth factor receptor; estrogen receptor; Ki67
|
Indexed keywords
EPIDERMAL GROWTH FACTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ESTROGEN;
ESTROGEN RECEPTOR;
MONOCLONAL ANTIBODY KI 67;
ONCOPROTEIN;
RECEPTOR PROTEIN;
ARTICLE;
BREAST CANCER;
CANCER HORMONE THERAPY;
CANCER REGRESSION;
CELL ONCOGENE;
FEMALE;
HUMAN;
HUMAN TISSUE;
IMMUNOCYTOCHEMISTRY;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
BREAST NEOPLASMS;
COMPARATIVE STUDY;
FEMALE;
GOSERELIN;
HUMAN;
KI-67 ANTIGEN;
MEGESTROL;
MEGESTROL ACETATE;
MENOPAUSE;
NEOPLASM PROTEINS;
NUCLEAR PROTEINS;
POSTMENOPAUSE;
PREMENOPAUSE;
PROGNOSIS;
PROTO-ONCOGENE PROTEINS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RECEPTOR, ERBB-2;
RECEPTORS, ESTROGEN;
SUPPORT, NON-U.S. GOV'T;
SURVIVAL ANALYSIS;
TAMOXIFEN;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0028293921
PISSN: 01676806
EISSN: 15737217
Source Type: Journal
DOI: 10.1007/BF00666187 Document Type: Editorial |
Times cited : (173)
|
References (27)
|